Chimerix Company
Chimerix is a biotechnology company developing therapeutics for antiviral diseases.
Investors
Technology:
Cell-based gene therapy, Stem Cell
Industry:
Public, Regenerative medicine
Headquarters:
Durham, North Carolina, United States
Founded Date:
2002-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
12
Total Funding:
443249178
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-11-08
Last Funding Type:
Grant
Register and Claim Ownership